Godwin Immanuel

Godwin Immanuel has a diverse background in the field of life sciences and biology. In 2014, they worked as a Research Intern at Mayopathy and Research Centre, where they conducted a case study on Duchenne muscular dystrophy. In 2015, they joined the Zebrafish Genetics Laboratory at SRM University as a Bachelor Research Student, studying the effects of the NMDA receptor antagonist Ketamine on neurotransmitter systems in zebrafish. In 2017, they co-created Rare Disease Day in India as a project at SRM University. From 2017 to present, Godwin has been a Co-Founder and Chief of People at Cambrionics Life Science, a company focused on hands-on and research-based learning in life science and biology. Most recently, in 2022, they became the Co-Founder and CMO of Bversity.

Godwin Immanuel completed their Bachelor of Technology degree in Genetics from SRM University between 2014 and 2018. Prior to that, they attended Nazareth Matriculation Higher Secondary School from 1998 to 2013, where they completed their 12th grade with a focus on BIO-MATH.